Bill Sorabella

Partner
Full contact info

Experience

Tourmaline Bio Agrees to Merge With Talaris Therapeutics

June 22, 2023

Cooley advised Tourmaline Bio, a late-stage clinical biotechnology company, on its merger agreement with Talaris Therapeutics, including a concurrent private placement.

Read more

Related contacts

Bill Sorabella
Partner, New York
Brandon W. Fenn
Partner, New York
Matthew D. Silverman
Special Counsel, San Diego
Christine Tse
Associate, New York
Emily Hong
Associate, New York
Katherine Denby
Associate, Washington DC
Daniel Chao
Associate, New York
Jeffrey Libson
Partner

Related Practices & Industries

Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction

January 9, 2023

Cooley advised Amryt Pharma, a Dublin, Ireland-based commercial-stage biopharmaceutical company, on its definitive agreement to be acquired by Chiesi Farmaceutici, a Parma, Italy-based research-focused biopharmaceuticals and healthcare group, in a $1.48 billion cash and contingent value right (CVR) transaction. Partners Bill Sorabella, Claire Keast-Butler and Bill Roegge led the joint US and UK Cooley team advising Amryt.

Related contacts

Bill Sorabella
Partner, New York
Claire Keast-Butler
Partner, London
Bill Roegge
Partner, New York
Jacqueline Grise
Partner, Washington DC
Christopher Kimball
Partner, Washington DC
Eileen Marshall
Partner, Washington DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Nicola Squire
Partner, London
David Wilson
Partner, London
David Burns
Special Counsel, Washington DC
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
Joyce Li
Associate, Chicago
Mor Agam
Associate, New York
Karun Ahuja
Associate, Chicago
Russell Anderson
Associate, London
Jack Jones
Associate, London
Pat O'Connell
Associate, New York
Jia Xie
Associate, London
Anthony Hajj
Associate, New York

Related Practices & Industries

Rankings & accolades

  • Chambers USA: America's Leading Lawyers for Business in Corporate/M&A
  • The Legal 500 US: M&A: mega-deals ($1 billion+)
  • The American Lawyer: Dealmakers of the Year (2010 and 2012)
  • Law360: Rising Star and M&A MVP
  • Super Lawyers: New York Rising Star